These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7504717)

  • 41. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
    Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
    Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Etiologic diagnosis of hepatic lesions in cancer patients. Value of ultrasound and liver function tests.
    Bruneton JN; Raffaelli C; Padovani B; Maestro C; Chevallier P; Mourou MY
    Clin Imaging; 1997; 21(5):366-71. PubMed ID: 9316758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
    Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
    World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
    Song BC; Chung YH; Kim JA; Choi WB; Suh DD; Pyo SI; Shin JW; Lee HC; Lee YS; Suh DJ
    Cancer; 2002 Jan; 94(1):175-80. PubMed ID: 11815974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
    Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F;
    Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K; Shiraki K; Nakanishi S; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Fuke H; Hashimoto A; Shimizu A; Okuda Y; Nakano T
    Int J Oncol; 2003 Feb; 22(2):353-8. PubMed ID: 12527934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrasound-guided fine needle biopsy of intrahepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma.
    He YM; Wang XY; Gao SD; Yu LY; Lin XD; Lin LW
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):50-4. PubMed ID: 15730919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
    Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbon dioxide-enhanced ultrasonography of liver tumors.
    Chen RC; Wang CS; Chen PH; Tu HY; Chiang LC; Liu JD
    J Ultrasound Med; 1994 Feb; 13(2):81-6. PubMed ID: 7932965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a monoclonal immunoenzymometric assay for alpha-fetoprotein.
    Chan DW; Kelsten M; Rock R; Bruzek D
    Clin Chem; 1986 Jul; 32(7):1318-22. PubMed ID: 2424638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
    Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T
    Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent hepatocellular carcinoma: usefulness of ultrasonography compared with computed tomography and AFP assay.
    Shibata T; Kubo S; Itoh K; Sagoh T; Nishimura K; Nakano Y; Yamaoka Y; Ozawa K; Konishi J
    J Clin Ultrasound; 1991 Oct; 19(8):463-9. PubMed ID: 1719036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
    Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
    Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver tumors in fatty liver: difficulty in ultrasonographic interpretation.
    Konno K; Ishida H; Sato M; Komatsuda T; Ishida J; Naganuma H; Hamashima Y; Watanabe S
    Abdom Imaging; 2001; 26(5):487-91. PubMed ID: 11503085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of 99mTc-labeled red blood cell SPET for a solitary solid liver mass in HBV carrier patients with different echogenicities.
    Tzen KY; Yen TC; Lin WY; Tsai CC; Lin KJ
    Hepatogastroenterology; 2000; 47(35):1375-8. PubMed ID: 11100355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
    Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2979-82. PubMed ID: 11712797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.